CAS: 1256393-27-7
2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[6-[9,9-difluoro-7-[2-[(6S)-5-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-azaspiro[2.4]hept-6-yl]-1H-imidazol-5-yl]-9H-fluoren-2-yl]-1H-benzimidazol-2-yl]-, 1,1-dimethylethyl ester, (1R,3S,4S)-
CAS:1256393-27-7
Fórmula:
C47H51F2N7O5
Pureza:
98%
Peso molecular:
831.9485
Ref: IN-DA000O84
100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 5 de Dezembro de 2024
tert-butyl (1R,3S,4S)-3-[6-(9,9-difluoro-7-{2-[(6S)-5-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-5-azaspiro[2.4]heptan-6-yl]-1H-imidazol-4-yl}-9H-fluoren-2-yl)-1H-1,3-benzodiazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylate
CAS:1256393-27-7
Pureza:
98%
Peso molecular:
831.9660034179688
Ref: 10-F861618
25mg | 1.053,00 € |
Entrega estimada em Estados Unidos, Terça-feira 10 de Dezembro de 2024
Ledipasvir Intermediate
CAS:1256393-27-7
Ledipasvir intermediate is a by-product of the synthesis of ledipasvir. It is a monoamide that …
Fórmula:
C47H51F2N7O5
Pureza:
Min. 95%
Peso molecular:
831.95 g/mol
Ref: 3D-GAC39327
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 16 de Janeiro de 2025